Tilray announced its Portugal-based subsidiary completed a harvest of medical cannabis.

Tilray (NASDAQ:TLRY) announced its Portugal-based subsidiary completed a harvest of medical cannabis.

As quoted in the press release:

“Our harvest in Portugal is an exciting milestone for the company as we continue to build our multinational supply chain of high-quality medical cannabis,” said Sascha Mielcarek, Managing Director, Europe. “We look forward to utilizing the capacity of Tilray Portugal to supply the medical cannabis market in Europe as we expand our operations.”
Tilray was the first licensed medical cannabis producer to successfully import medical cannabis products into the EU and the first licensed medical cannabis producer in North America to obtain Good Manufacturing Practice (GMP) certification in accordance with the European Medicines Agency’s (EMA) standards. Tilray has established sales and distribution arrangements to distribute medical cannabis through major pharmaceutical distribution channels throughout Germany and the European Union.

Click here to read the full press release.

europe nasdaq:tlry portugal Cannabis Investing